• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义肠道微生物生态系统成分对艰难梭菌毒力决定因素的影响。

Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile.

机构信息

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Division of Infectious Diseases/Gastrointestinal Diseases Research Unit, Department of Medicine, Queen's University, Kingston, Ontario, Canada.

出版信息

Sci Rep. 2019 Jan 29;9(1):885. doi: 10.1038/s41598-018-37547-x.

DOI:10.1038/s41598-018-37547-x
PMID:30696914
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6351598/
Abstract

Many cases of Clostridioides difficile infection (CDI) are poorly responsive to standard antibiotic treatment strategies, and often patients suffer from recurrent infections characterized by severe diarrhea. Our group previously reported the successful cure of two patients with recurrent CDI using a standardized stool-derived microbial ecosystem therapeutic (MET-1). Using an in vitro model of the distal gut to support bacterial communities, we characterized the metabolite profiles of two defined microbial ecosystems derived from healthy donor stool (DEC58, and a subset community, MET-1), as well as an ecosystem representative of a dysbiotic state (ciprofloxacin-treated DEC58). The growth and virulence determinants of two C. difficile strains were then assessed in response to components derived from the ecosystems. CD186 (ribotype 027) and CD973 (ribotype 078) growth was decreased upon treatment with DEC58 metabolites compared to ciprofloxacin-treated DEC58 metabolites. Furthermore, CD186 TcdA and TcdB secretion was increased following treatment with ciprofloxacin-treated DEC58 spent medium compared to DEC58 spent medium alone. The net metabolic output of C. difficile was also modulated in response to spent media from defined microbial ecosystems, although several metabolite levels were divergent across the two strains examined. Further investigation of these antagonistic properties will guide the development of microbiota-based therapeutics for CDI.

摘要

许多艰难梭菌感染(CDI)病例对标准抗生素治疗策略反应不佳,并且患者经常遭受复发性感染,其特征是严重腹泻。我们的小组之前曾报道过使用标准化粪便衍生微生物生态治疗(MET-1)成功治愈了两名复发性 CDI 患者。我们使用支持细菌群落的远端肠道体外模型,对源自健康供体粪便的两个定义微生物生态系统(DEC58 和亚群社区 MET-1)以及代表生态失调状态的生态系统(环丙沙星处理的 DEC58)的代谢物谱进行了特征描述。然后,评估了两种艰难梭菌菌株对生态系统衍生成分的生长和毒力决定因素的反应。与环丙沙星处理的 DEC58 代谢物相比,用 DEC58 代谢物处理时 CD186(基因型 027)和 CD973(基因型 078)的生长减少。此外,与单独用 DEC58 耗尽的培养基处理相比,用环丙沙星处理的 DEC58 耗尽的培养基处理后 CD186 TcdA 和 TcdB 的分泌增加。尽管在两种研究的菌株中,有几个代谢物水平存在差异,但对定义的微生物生态系统的耗尽培养基的反应也调节了艰难梭菌的净代谢产物。进一步研究这些拮抗特性将有助于开发用于 CDI 的基于微生物组的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/97312537a9d0/41598_2018_37547_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/4ef4dec3dc24/41598_2018_37547_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/64164a8ece1d/41598_2018_37547_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/8d86a41e5c60/41598_2018_37547_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/aa728ce97e38/41598_2018_37547_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/97312537a9d0/41598_2018_37547_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/4ef4dec3dc24/41598_2018_37547_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/64164a8ece1d/41598_2018_37547_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/8d86a41e5c60/41598_2018_37547_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/aa728ce97e38/41598_2018_37547_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9347/6351598/97312537a9d0/41598_2018_37547_Fig5_HTML.jpg

相似文献

1
Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile.定义肠道微生物生态系统成分对艰难梭菌毒力决定因素的影响。
Sci Rep. 2019 Jan 29;9(1):885. doi: 10.1038/s41598-018-37547-x.
2
Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.伊朗西南部犊牛粪便中艰难梭菌tcdA、tcdB、cdtA和cdtB基因频率的研究。
Ann Clin Microbiol Antimicrob. 2014 Jun 5;13:21. doi: 10.1186/1476-0711-13-21.
3
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.确定艰难梭菌感染期间TcdA和TcdB在局部胃肠道疾病、全身器官损伤及宿主反应中的作用。
mBio. 2015 Jun 2;6(3):e00551. doi: 10.1128/mBio.00551-15.
4
uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.使用与部分腹泻患者肠道微生物失调相关的氨基酸。
Sci Transl Med. 2018 Oct 24;10(464). doi: 10.1126/scitranslmed.aam7019.
5
Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.稀释粪菌移植可恢复抗生素扰乱的小鼠群落中艰难梭菌的定植抗性。
mBio. 2022 Aug 30;13(4):e0136422. doi: 10.1128/mbio.01364-22. Epub 2022 Aug 1.
6
Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.尽管犬类细胞容易受到其毒素的影响,但在存在艰难梭菌(梭状芽孢杆菌)的情况下,犬类不会出现肠道微生物失调的迹象。
Anaerobe. 2019 Aug;58:53-72. doi: 10.1016/j.anaerobe.2019.03.017. Epub 2019 Apr 1.
7
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.RBX2660 在 PUNCH CD3 中的疗效和安全性:一项 III 期、随机、双盲、安慰剂对照试验,采用贝叶斯主要分析预防复发性艰难梭菌感染。
Drugs. 2022 Oct;82(15):1527-1538. doi: 10.1007/s40265-022-01797-x. Epub 2022 Oct 26.
8
The microbial metabolite urolithin A reduces toxin expression and toxin-induced epithelial damage.微生物代谢产物尿石素A可降低毒素表达及毒素诱导的上皮损伤。
mSystems. 2024 Feb 20;9(2):e0125523. doi: 10.1128/msystems.01255-23. Epub 2024 Jan 9.
9
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.BaiCD 基因簇丰度与艰难梭菌感染呈负相关。
PLoS One. 2018 May 8;13(5):e0196977. doi: 10.1371/journal.pone.0196977. eCollection 2018.
10
Gut microbiota in burned patients with Clostridioides difficile infection.烧伤合并艰难梭菌感染患者的肠道菌群。
Burns. 2022 Aug;48(5):1120-1129. doi: 10.1016/j.burns.2021.11.023. Epub 2021 Dec 1.

引用本文的文献

1
Characterization of diet-linked amino acid pool influence on spp. growth and metabolism.饮食相关氨基酸库对 spp. 生长和代谢影响的表征。
mSphere. 2025 Mar 25;10(3):e0078924. doi: 10.1128/msphere.00789-24. Epub 2025 Feb 13.
2
Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota.饮食治疗的妊娠期糖尿病女性对食物血糖反应的个性化预测:肠道微生物群的作用
NPJ Biofilms Microbiomes. 2025 Feb 7;11(1):25. doi: 10.1038/s41522-025-00650-9.
3
Host Immune Responses to Infection and Potential Novel Therapeutic Approaches.

本文引用的文献

1
Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization.在初始感染期间改变不同盲肠微生物组的结构和代谢,以促进持续定植。
mSphere. 2018 Jun 27;3(3). doi: 10.1128/mSphere.00261-18.
2
Shifts in the Gut Metabolome and Transcriptome throughout Colonization and Infection in a Mouse Model.肠道代谢组和转录组在小鼠模型中的定植和感染过程中的变化。
mSphere. 2018 Mar 28;3(2). doi: 10.1128/mSphere.00089-18. eCollection 2018 Mar-Apr.
3
Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota.
宿主对感染的免疫反应及潜在的新型治疗方法。
Trop Med Infect Dis. 2023 Nov 23;8(12):506. doi: 10.3390/tropicalmed8120506.
4
Network analysis of toxin production in Clostridioides difficile identifies key metabolic dependencies.网络分析艰难梭菌毒素产生识别关键代谢依赖性。
PLoS Comput Biol. 2023 Apr 26;19(4):e1011076. doi: 10.1371/journal.pcbi.1011076. eCollection 2023 Apr.
5
Enterohemorrhagic responds to gut microbiota metabolites by altering metabolism and activating stress responses.肠出血性大肠杆菌通过改变代谢和激活应激反应来响应肠道微生物群代谢物。
Gut Microbes. 2023 Jan-Dec;15(1):2190303. doi: 10.1080/19490976.2023.2190303.
6
Synthetic microbial communities (SynComs) of the human gut: design, assembly, and applications.合成微生物群落(SynComs)在人类肠道中的应用:设计、组装和应用。
FEMS Microbiol Rev. 2023 Mar 10;47(2). doi: 10.1093/femsre/fuad012.
7
Immunological consequences of microbiome-based therapeutics.基于微生物组的治疗方法的免疫学后果。
Front Immunol. 2023 Jan 12;13:1046472. doi: 10.3389/fimmu.2022.1046472. eCollection 2022.
8
Updating changes in human gut microbial communities associated with infection.更新与感染相关的人类肠道微生物群落变化。
Gut Microbes. 2021 Jan-Dec;13(1):1966277. doi: 10.1080/19490976.2021.1966277.
9
Bacteriotherapy for inflammatory bowel disease.炎症性肠病的细菌疗法。
Inflamm Regen. 2021 Jan 13;41(1):3. doi: 10.1186/s41232-020-00153-4.
10
1D H NMR as a Tool for Fecal Metabolomics.1D H NMR 作为粪便代谢组学的研究工具。
Curr Protoc Chem Biol. 2020 Sep;12(3):e83. doi: 10.1002/cpch.83.
肥胖症患者血液中琥珀酸水平升高与特定的肠道微生物群有关。
ISME J. 2018 Jun;12(7):1642-1657. doi: 10.1038/s41396-018-0068-2. Epub 2018 Feb 12.
4
Dietary trehalose enhances virulence of epidemic Clostridium difficile.饮食海藻糖可增强流行艰难梭菌的毒力。
Nature. 2018 Jan 18;553(7688):291-294. doi: 10.1038/nature25178. Epub 2018 Jan 3.
5
Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.口服胶囊与结肠镜检查递送粪便微生物群移植对复发性艰难梭菌感染的影响:一项随机临床试验
JAMA. 2017 Nov 28;318(20):1985-1993. doi: 10.1001/jama.2017.17077.
6
Colonizes Alternative Nutrient Niches during Infection across Distinct Murine Gut Microbiomes.在感染过程中,跨不同小鼠肠道微生物群定殖于替代性营养生态位。
mSystems. 2017 Jul 25;2(4). doi: 10.1128/mSystems.00063-17. eCollection 2017 Jul-Aug.
7
Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study.美国多重复发艰难梭菌感染发病率的增加:一项队列研究。
Ann Intern Med. 2017 Aug 1;167(3):152-158. doi: 10.7326/M16-2733. Epub 2017 Jul 4.
8
European consensus conference on faecal microbiota transplantation in clinical practice.临床实践中粪便微生物群移植欧洲共识会议
Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13.
9
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.完全微生物群植入对于粪便微生物群移植后复发性艰难梭菌感染的恢复并非必不可少。
mBio. 2016 Dec 20;7(6):e01965-16. doi: 10.1128/mBio.01965-16.
10
The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile.磷酸转移蛋白CD1492抑制艰难梭菌的孢子形成起始。
Infect Immun. 2016 Nov 18;84(12):3434-3444. doi: 10.1128/IAI.00735-16. Print 2016 Dec.